ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) ROI
- 2026-06-30: ROI 8.66%.
- 2026-03-31: ROI -0.79%.
- 2025-12-31: ROI -5.41%.
- 2025-09-30: ROI -16.63%.
Complete source-backed roi history.
- Available history
- 2023-12-31 to 2026-06-30
- Data captured
Historical ROI
| Date | ROI |
|---|---|
| 2026-06-30 | 8.66% |
| 2026-03-31 | -0.79% |
| 2025-12-31 | -5.41% |
| 2025-09-30 | -16.63% |
| 2025-06-30 | -37.76% |
| 2024-12-31 | -52.90% |
| 2024-09-30 | -54.13% |
| 2023-12-31 | -90.25% |
Annual ROI
| Date | ROI |
|---|---|
| 2025-12-31 | -5.41% |
| 2024-12-31 | -52.90% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 |